What is CaNCURE?

CaNCURE was created to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Over 50 trainees have already completed the program.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research lab.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
 Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.

60

Trainees

33

Mentors

17

Publications

100

Presentations


Hear from our Alumni:

“Not many 21-year-old college kids have the opportunity to work with experienced, well-known cancer researchers in some of the most well-respected medical institutions in the world.  To say that I have the chance to meet and learn from these men and women is truly both an honor and a privilege.”

Craig Pille, Health Sciences, ’16


Trainee Spotlight


Pamela Guerra

Cell and Molecular Biology, '21

Use of CT Texture Analysis for Characterization and Prognostication of Incidental Adnexal Lesions

Evan Mun

Biochemistry, '20

Discovering the Genetic Mechanism of Enhanced Metastatic Colonization in SMAD4 Mutant Tumors

Neha Shankar

Health Science, '19

Development of Smart INCeRT Brachytherapy Spacers via PLGA and Docetaxel for Combined Chemo-Radiation Therapies in Prostate Cancer


Upcoming Events

Check back soon for new events


Mentor Spotlight


Ralph Weissleder, M.D., Ph.D.

Professor of Radiology, HMS

Our lab aims to use novel imaging and sensing techniques to measure major protein and network hubs of interest in a quantitative and predictive manner. Students will combine advanced microscopic imaging with systemically injectable nanoparticle-based sensors to perform quantitative single cell analysis of cancers during drug treatments in vivo.


Bryan Spring, Ph.D.

Assistant Professor, NEU

The ultimate goal of the program is to reduce cancer recurrence and mortality by establishing new approaches for personalized medicine that address tumor heterogeneity, drug-resistance and molecular mechanisms of treatment escape. Advanced-stage cancer patients are presently subjected to a grueling treatment regimen consisting of surgical tumor debulking and high-dose-intensity chemotherapy. These standard approaches frequently hit a wall due to dose-limiting toxicities as well as mechanisms of drug-resistance and treatment escape via cell signaling networks.


Trainee Spotlight


Patrick Sheedy

Health Sciences, '19

Investigation of a miRNA associated with cancer metastasis. Proj 2-Development of a novel nanoparticle for MPI analysis of thromboses

Justin Margolin

Health Science, '19

Evaluation of deep learning approaches in an integrated PET/MRI scanner to generate pelvis attenuation maps and characterize prostate cancer

Evan Mun

Biochemistry, '20

Discovering the Genetic Mechanism of Enhanced Metastatic Colonization in SMAD4 Mutant Tumors


 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 8 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in October 2018 via NUcareers.

Going on in the lab right now...